{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:51:58Z","timestamp":1791503518936,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009098","name":"Japanese Respiratory Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.resinv.2026.101482","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:54:47Z","timestamp":1784073287000},"page":"101482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The JRS guideline for the management of chronic obstructive pulmonary disease 7th edition 2026"],"prefix":"10.1016","volume":"64","author":[{"given":"Hisatoshi","family":"Sugiura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3174-2632","authenticated-orcid":false,"given":"Naoya","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1794-0026","authenticated-orcid":false,"given":"Yoko","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7452-9191","authenticated-orcid":false,"given":"Shigeo","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0514-3241","authenticated-orcid":false,"given":"Kazuto","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Horita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomotaka","family":"Kawayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2026.101482_bib1","series-title":"The JRS guideline for the management of chronic obstructive pulmonary disease 2026","year":"2026"},{"key":"10.1016\/j.resinv.2026.101482_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1440-1843.2004.00637.x","article-title":"COPD in Japan: the nippon COPD epidemiology study","volume":"9","author":"Fukuchi","year":"2004","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2026.101482_bib3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2147\/COPD.S450270","article-title":"Underdiagnosis of COPD: the Japan COPD real-world data Epidemiological (CORE) study","volume":"19","author":"Koga","year":"2024","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.resinv.2026.101482_bib4","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1183\/09031936.00110213","article-title":"Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study","volume":"43","author":"Suzuki","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2026.101482_bib5","first-page":"3459","article-title":"Understanding low COPD exacerbation rates in Japan: a review and comparison with other countries","volume":"13","author":"Ishii","year":"2018","journal-title":"Int J Chronic Obstr"},{"key":"10.1016\/j.resinv.2026.101482_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.alit.2023.08.003","article-title":"Exacerbation rates in Japanese patients with obstructive lung disease: a subanalysis of the prospective, observational NOVELTY study","volume":"73","author":"Kawayama","year":"2024","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2026.101482_bib7","article-title":"Summary of the Japanese respiratory society guidelines for the diagnosis and treatment of asthma and chronic obstructive pulmonary disease overlap 2023","volume":"vol. 64","author":"Muro","year":"2026"},{"key":"10.1016\/j.resinv.2026.101482_bib8","first-page":"37","article-title":"Real-world evidence on the diagnostic and clinical characteristics of asthma in Japanese patients with COPD: the ACO Japan cohort study","volume":"18","author":"Hashimoto","year":"2023","journal-title":"Int J Chronic Obstr"},{"key":"10.1016\/j.resinv.2026.101482_bib9","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaci.2019.04.023","article-title":"Nitrosative stress in patients with asthma\u2013chronic obstructive pulmonary disease overlap","volume":"144","author":"Kyogoku","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2026.101482_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1164\/rccm.202301-0106PP","article-title":"Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary","volume":"207","author":"Agust\u00ed","year":"2023","journal-title":"Am J Resp Crit Care"},{"key":"10.1016\/j.resinv.2026.101482_bib11","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s42003-021-02813-8","article-title":"Genetic loci for lung function in Japanese adults with adjustment for exhaled nitric oxide levels as airway inflammation indicator","volume":"4","author":"Yamada","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.resinv.2026.101482_bib12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3390\/diagnostics11050859","article-title":"ACO (Asthma\u2013COPD overlap) is independent from COPD, a case in favor: a systematic review","volume":"11","author":"Fujino","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.resinv.2026.101482_bib13","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2023.2065","article-title":"Airway-occluding mucus plugs and mortality in patients with chronic obstructive pulmonary disease","volume":"329","author":"Diaz","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2026.101482_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1165\/rcmb.2013-0382PS","article-title":"Senescence-associated secretory phenotype and its possible role in chronic obstructive pulmonary disease","volume":"51","author":"Kumar","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2026.101482_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001553","article-title":"Gene expression profiles of alveolar type II cells of chronic obstructive pulmonary disease: a case-control study","volume":"2","author":"Fujino","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.resinv.2026.101482_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12931-020-1297-2","article-title":"Decreased expression of a phagocytic receptor Siglec-1 on alveolar macrophages in chronic obstructive pulmonary disease","volume":"21","author":"Tanno","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2026.101482_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1164\/rccm.202303-0534OC","article-title":"A single-cell atlas of small airway disease in chronic obstructive pulmonary disease: a cross-sectional study","volume":"208","author":"Booth","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101482_bib18","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/resp.14325","article-title":"Treatable traits in the NOVELTY study","volume":"27","author":"Agust\u00ed","year":"2022","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2026.101482_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1164\/rccm.202310-1848OC","article-title":"Characterization and mortality risk of impaired left ventricular filling in chronic obstructive pulmonary disease","volume":"211","author":"Abdo","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101482_bib20","article-title":"Time\u2010dependent risk of cardiovascular events following an exacerbation in patients with chronic obstructive pulmonary disease: post hoc analysis from the IMPACT trial","volume":"11","author":"Dransfield","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.resinv.2026.101482_bib21","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1007\/s12325-024-02920-y","article-title":"Increased risk of severe cardiovascular events following exacerbations of chronic obstructive pulmonary disease: results of the EXACOS-CV study in Japan","volume":"41","author":"Matsunaga","year":"2024","journal-title":"Adv Ther"},{"key":"10.1016\/j.resinv.2026.101482_bib22","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1164\/rccm.202307-1122OC","article-title":"Temporal risk of nonfatal cardiovascular events after chronic obstructive pulmonary disease exacerbation: a population-based study","volume":"209","author":"Graul","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2026.101482_bib23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1183\/23120541.01091-2024","article-title":"The sustained increase of cardiovascular risk following COPD exacerbations: meta-analyses of the EXACOS-CV studies","volume":"11","author":"Nordon","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.resinv.2026.101482_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1183\/23120541.00399-2021","article-title":"ROSE: radiology, obstruction, symptoms and exposure \u2013 a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC airways working group","volume":"7","author":"Traversi","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.resinv.2026.101482_bib25","article-title":"Heterogeneities and impact profiles of early chronic obstructive pulmonary disease status: findings from the China pulmonary health study","volume":"45","author":"Lei","year":"2024","journal-title":"Lancet Reg Heal - West Pac"},{"key":"10.1016\/j.resinv.2026.101482_bib26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1183\/23120541.00334-2022","article-title":"Unravelling young COPD and pre-COPD in the general population","volume":"9","author":"Cos\u00edo","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.resinv.2026.101482_bib27","article-title":"Toward a third term of health Japan 21 \u2013 implications from the rise in non-communicable disease burden and highly preventable risk factors","volume":"21","author":"Nomura","year":"2022","journal-title":"Lancet Reg Heal - West Pac"},{"key":"10.1016\/j.resinv.2026.101482_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2213-2600(19)30276-0","article-title":"Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI pooled cohorts study","volume":"8","author":"Oelsner","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2026.101482_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2303951","article-title":"Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts","volume":"389","author":"Bhatt","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101482_bib30","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJMoa2401304","article-title":"Dupilumab for COPD with blood eosinophil evidence of type 2 inflammation","volume":"390","author":"Bhatt","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2026.101482_bib31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/15412555.2023.2219742","article-title":"Development of a communication tool between patients and physicians for recognizing COPD exacerbations in Japan","volume":"20","author":"Jones","year":"2023","journal-title":"COPD: J Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.resinv.2026.101482_bib32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12890-022-01958-4","article-title":"Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis","volume":"22","author":"Hoult","year":"2022","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2026.101482_bib33","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.chest.2021.05.024","article-title":"Personalized variable vs fixed-dose systemic corticosteroid therapy in hospitalized patients with acute exacerbations of COPD A prospective, multicenter, randomized, open-label clinical trial","volume":"160","author":"Li","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2026.101482_bib34","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2013.5023","article-title":"Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial","volume":"309","author":"Leuppi","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2026.101482_bib35","article-title":"COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months","volume":"6","author":"Sivapalan","year":"2019","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.resinv.2026.101482_bib36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.resinv.2024.03.009","article-title":"Treatment with systemic corticosteroid versus placebo for exacerbations of COPD: a systematic review and meta-analysis","volume":"62","author":"Koarai","year":"2024","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2026.101482_bib37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.resinv.2024.05.007","article-title":"Antibiotic treatment for patients with exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"62","author":"Suzuki","year":"2024","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2026.101482_bib38","first-page":"CD004104","article-title":"Non\u2010invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease","volume":"2017","author":"Osadnik","year":"2017","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526001164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526001164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:24:52Z","timestamp":1791501892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534526001164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2212534526001164"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101482","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The JRS guideline for the management of chronic obstructive pulmonary disease 7th edition 2026","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of The Japanese Respiratory Society.","name":"copyright","label":"Copyright"}],"article-number":"101482"}}